| Date | Time | Source | Headline | Symbol | Company |
| 04/19/2010 | 7:54AM | Dow Jones News | Amylin 1Q Loss Narrows On Lower Costs; Revenue, Margin Fall | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 7:21AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 7:00AM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/13/2010 | 9:07AM | Dow Jones News | Alkermes Submits FDA Application To Expand Vivitrol Approval | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/12/2010 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast First Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/06/2010 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/26/2010 | 2:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/19/2010 | 9:18AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/16/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/16/2010 | 8:45AM | Marketwired | Market Pulse Breaking News Alert for Tuesday, March 16, 2010: EBIG -- EastBridge Investment Group Announces Tsingda Century Educ | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 5:07PM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Make Late-day Rise, Helped By Wal-Mart | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 4:29PM | DPA AFX Nachrichten | ROUNDUP/Aktien New York Schluss: Späte Rally verhilft Dow Jones ins Plus | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 4:10PM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Turn Higher As Wal-Mart Gains | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 2:29PM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Fall As Oil, Energy Stocks Decline | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 12:02PM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Sink As Oil, Energy Stocks Slide | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 11:22AM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Pressured By Falling Oil, Google | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 10:53AM | DPA AFX Nachrichten | ROUNDUP/Aktien New York: Leichte Verluste - Sorgen über Chinas Geldpolitik | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 10:41AM | Dow Jones News | 2nd UPDATE: FDA Rejects Amylin Diabetes Drug, Seeks More Info | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 10:10AM | Dow Jones News | MARKET SNAPSHOT: U.S. Stocks Mostly Lower; Google Dips, Wal-Mart Up | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 9:31AM | Dow Jones News | UPDATE: FDA Seeks More Info In Rejecting Amylin Diabetes Drug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 7:14AM | Dow Jones News | FDA: No New Requests For Clinical Data On Amylin Diabetes Drug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 6:15AM | Business Wire | Amylin, Lilly and Alkermes Receive Complete Response Letter from FDA for exenatide Once Weekly Submission | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/15/2010 | 2:00AM | PR Newswire (US) | Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/10/2010 | 5:24PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/10/2010 | 5:23PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |